Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Jornadas #PatientInHTA · Gaizka Benguria

347 views

Published on

Presentation in the framework of the International Conference "10th

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Jornadas #PatientInHTA · Gaizka Benguria

  1. 1. Zaragoza, 27-28 April 2017 Are we able to detect new technologies systematically and timely? Spanish emerging technologies network. Methodological advances and work plan. E. Baños, S. Luengo, A. Llanos, C. Juárez, L Varela, JM. Ruiz-Olano I. Prieto, T. Molina, I. Gutiérrez-Ibarluzea, G. Benguria-Arrate, J. Asua AETS, AETSA, AVALIA-T, OSTEBA PUBLIC HEALTH CONFERENCE 10th anniversary of the Spanish Network of Health Technology Assessment (HTA) Agencies: Insights for collaborative networking Towards Patient and public engagement in HTA
  2. 2. Agenda • Where we come from? • What is our way? • Changes over time • What can we offer? • What do we need from the system and from our customers? • Future developments
  3. 3. New or emerging health technologies • Emerging health technology A health technology that has not yet been adopted within the healthcare system. Pharmaceuticals are in the Phase II or III clinical trial, or pre-launch stage; medical devices are in the pre-marketing stage. • New health technology A health technology that is in the launch, early post- marketing, or early diffusion stages. Source: https://www.euroscan.org/
  4. 4. Introduction of new and emerging health technologies Innovation Development Security and efficacy Technology analysis Technology Assessment Decision Clinical Practice Producers Buyers Supliers Health professionals Professional bodies Public Health Politicians Mass-media Pressure groups (ej. Religion) Patient organizations Society Patients John Gabbay and Tom Walley Introducing new health interventions BMJ, Jan 2006; 332: 64 - 6 Political strategists
  5. 5. When to evaluate?….When to inform?…. Experimental Clinical research Acceptance Phase Accepted and disseminated Introduced into the system Innovation Amount of information Assessment Variability Early dialogue Inform
  6. 6. Diffusion control strategies • Early awareness and alert system A system that aims to identify, filter and prioritisize new and emerging health technologies, or new uses of existing interventions; to assess or predict their impact on health, health services and/or society; and to disseminate information. • Horizon scanning The systematic identification of health technologies that are new, emerging or becoming obsolete and that have the potential to effect health, health services and/or society. • Regulation for the introduction Informative Normative • Rational use of the technology
  7. 7. IMPACTO DE LOS SISTEMAS DE IDENTIFICACIÓN-EVALUACIÓN DE TECNOLOGÍAS SANITARIAS NUEVAS Y EMERGENTES EN LA DIFUSIÓN-INTRODUCCIÓN DE DICHAS TECNOLOGÍAS Noviembre 2006 • I Gutiérrez-Ibarluzea1, S. Luengo2, R. Villegas3. L. Varela4, • T. Cerdá4, J Asua1, N Egües-Olazabal1. • 1 Osteba. Osasun Teknologien Ebaluazioa. Osasun Saila. Eusko Jaurlaritza. • 2 AETS-Carlos III, Madrid 3 AETSA-Sevilla, Andalucía 4Avalia-T Santiago de Compostela. Galicia.
  8. 8. Where we come from?......Opportunity • Common working time – Experienced systems – Incipient systems – Not regulated established collaboration • Coordinated project between some health technology assessment agencies of regional Ministries of Health “We are what we do, day by day. So excellence is not an act, its a habit”. Aristotle
  9. 9. Objectives of the survey 2006 • To know the situation of the identification and evaluation of new and emerging technologies systems in the NHS • To evaluate the current impact of its recommendations on the dissemination of some health technologies • To establish the basis for a network of information on new and emerging health technologies in the NHS
  10. 10. Methodology (survey 2006) • Direct contact with the Spanish HTA organizations that have EWS / questionnaire description of those systems • Analysis of its influence on the diffusion
  11. 11. Identification-assessment systems in the National Health System – 2006- SorTek Detecta-T Síntesis Detecta
  12. 12. Conclusions (survey 2006) • Different systems, methodology and similar action • 3 EuroScan members (AETS, AETSA and Osteba) • High degree of agreement on the recommendations issued • Early Assessment Systems (EAS) modify the diffusion ratios of the technologies studied in health coverage contexts • Difficulties in obtaining data • Impact? – Higher or lower by the degree of influence of close contexts without EAS.
  13. 13. New challenges…in 2006 • To improve identification methodology • To be more proactive with experts • To increase information sources • Benchmarking • To increase the number of experts involved • To expand the survey to other centers with information- regulation systems in the NHS • To extend the experience to other communities with HTA units • To create an stable network that adequately and timely reports to the NHS
  14. 14. What is our way…? • To update the GENTecS Group's Early Detection Strategy for New and Emerging Health Technologies in order to adapt it to current needs • Autonomous entities and the General Directorate of Basic Service Portfolio of the MoH and Cohesion Fund of the Ministry of Health, Social Policies and Equality, and the Autonomous Communities, through the Performance, Insurance and Financing Commission, under the Interterritorial Council of the Spanish NHS.
  15. 15. A joint and harmonious work
  16. 16. Current actions • Development of a functional and operational working model in collaboration with the Gerneral directorate of Basic Services Portfolio of the NHS and Cohesion Fund of the Ministry of Health, Social Policies and Equality. • Translation and adaptation of the methodological tool created by EuroScan • Adaptation of the PriTec prioritization tool for use in the prioritization of new and emerging health technologies.
  17. 17. Things that have changed • Interlocution with the NHS • Influence on the portfolio of services • Presence in different commissions • Persistence • Improvement and methodological developments – Search – Prioritization – Evaluation – Format – GRADE
  18. 18. What can we offer? • A common database of new and emerging health technologies. • Facilitate the more efficient and exhaustive identification of technologies for the subsequent prioritization by the corresponding autonomous systems and by the Service Portfolio Directorate of the MoH. • Staff strategy • Continuous evaluation and improvement of the identification- assessment system.
  19. 19. What have we done already? • We continue working in a coordinated and joint manner • We have generated a list of new and emerging technologies in 2016 with 63 entries • Attractive formats for visualization and prioritization of the information about emerging technologies
  20. 20. What do we need from our system and from our customers? • Who? • For what? • What? Needs • Which one first? Priorities • When? Time • What? Information • How? Method
  21. 21. Future developments • Stakeholder engagement • Test different methodologies in development – Identification – Prioritization – Elaboration of recommendations • Evaluate the efficiency of the system and its impact • Find new partners and customers
  22. 22. What else..? Gaizka Benguria Arrate Osteba, Basque Office for Health Technology Assessment Basque Health Department Alda Rekalde 39A - Bilbao g-benguria@euskadi.eus http://www.osakidetza.euskadi.eus/osteba https://www.facebook.com/pages/Osteba/3 65563420144977

×